Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06162741 · ClinicalTrials.gov registry record · NA

Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans

A NA study of Depression and Anxiety, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT06162741: Recruiting NA study of Depression and Anxiety, sponsored by VA Office of Research and Development.

NCT06162741 is a NA study of Depression and Anxiety that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 300 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06162741, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

The VA wants to understand what type of integrative and whole health approaches are helpful for Veterans. The study is comparing two primary care based mental health treatments, a mindfulness class that teaches mindfulness meditation and a problem-solving class that teaches problem-solving skills and how to build resilience, for Veterans who are experiencing symptoms of anxiety, depression, and/or PTSD. The goal of the study is to understand if the classes reduce symptoms of anxiety, depression, and/or PTSD and increase overall functioning.

Primary Outcome

The Depression Anxiety and Stress Scale (DASS-21) is a widely used measurement for psychological symptoms and distress. It consists of 21 items measured on a 4-point scale. The three subscale scores for depression, anxiety, and stress are also valid measures of their constructs and will be used as secondary outcomes. Depression subscale range: 0-42 with higher scores meaning a worse outcome. Anxiety subscale range: 0-42 with higher scores meaning a worse outcome. Stress subscale range 0-21 with

Interventions

  • BEHAVIORAL Primary Care Brief Mindfulness Training (PCBMT)
  • BEHAVIORAL Moving Forward (MF)

Study Locations (4)

Arizona

  • Phoenix VA Health Care System, Phoenix, AZ - Phoenix

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Missouri

  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO - St Louis

New York

  • Syracuse VA Medical Center, Syracuse, NY - Syracuse

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-08-19
Est. Completion 2027-12-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06162741 shows while recruiting

NCT06162741 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (62% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Primary Care Brief Mindfulness Training (PCBMT) is the first listed.

NCT06162741 reports a single indexed study location in Arizona, California, Missouri.

Frequently Asked Questions

What is clinical trial NCT06162741 about?

NCT06162741 is a clinical study titled "Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans". The VA wants to understand what type of integrative and whole health approaches are helpful for Veterans. The study is comparing two primary care based mental health treatments, a mindfulness class that teaches mindfulness meditation and a problem-solving class that teaches problem-solving skills an...

What is the current status of trial NCT06162741?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-08-19. Estimated completion is 2027-12-31.

What conditions does trial NCT06162741 study?

This clinical trial studies the following conditions: Depression, Anxiety, Posttraumatic Stress Disorder (PTSD).

What interventions are being tested in trial NCT06162741?

The interventions under investigation include: Primary Care Brief Mindfulness Training (PCBMT) (BEHAVIORAL), Moving Forward (MF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06162741?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06162741 being conducted?

This trial has 4 study locations across Arizona, California, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06162741's enrollment target sits among peer trials

300 140th of 679 higher than 533 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06162741, the US trial registry maintained by the National Library of Medicine. NCT06162741 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.